End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 EUR | 0.00% | +1.19% | -58.33% |
May. 14 | Biophytis unveils design for obesity study | CF |
May. 14 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-58.33% | 2.42M | |
+7.83% | 115B | |
+12.83% | 107B | |
-13.22% | 22.31B | |
-3.99% | 21.6B | |
-6.42% | 18.23B | |
-39.93% | 17.62B | |
+6.87% | 14.26B | |
+32.83% | 12.37B | |
-28.19% | 8.28B |
- Stock Market
- Equities
- ALBPS Stock
- ALBPS Stock
- News Biophytis S.A.
- Biophytis Flags 'Significant Doubt' Over Ability to Continue Operations; to Launch Phase 2 Obesity Trial; Shares Rise Pre-Bell